Within the framework of the Ludwig Boltzmann Institute for Hematology and Oncology (LBI HO, formerly Ludwig Boltzmann Cluster Oncology (LBC ONC)), four project groups were initially formed
A: Myeloid neoplasms
B: Lymphatic neoplasms
C: Solid tumors (currently discontinued)
In each project group 5-6 projects were formulated and launched. The focus is the immunophenotypic characterization of the immature neoplastic cells, the identification of target structures (targets) on these cells and the evaluation of effects of targeted drugs. Moreover, in several diseases the immature neoplastic cells (stem cells) could be enriched by means of flow cytometry and partially, displayed in their pure form.